Previous studies have demonstrated the advantageous impacts of Sigmar1 on cardiac function and have identified this receptor as a potential target for the prevention and treatment of cardiovascular disease [22,23]. The gene discussed is SIGMAR1; the disease is cardiovascular disorder.